InvestorsHub Logo
Followers 1324
Posts 66548
Boards Moderated 12
Alias Born 01/24/2010

Re: ManicTrader post# 288

Wednesday, 04/20/2011 12:56:45 AM

Wednesday, April 20, 2011 12:56:45 AM

Post# of 4163
$NFRM is pleased to obtain the exclusive license to the technology on worldwide basis for GLB333. The product that has considerable data already, will be ready for clinical trials Phase I/II in near future," said Elaine Affleck, President of National Pharmaceuticals Corp. http://t.co/6g3n3KI 03/22/11


FOLLOW Us for Huge Picks at the StockGoodies Plays of the Week IHub Board http://investorshub.advfn.com/boards/board.aspx?board_id=18582